ConductScience.org, home

Paper39021815

Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.

Farhadnejad H and 9 others. J Nutr Metab, 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies. Papers, record 39021815. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39021815

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.
PubMed
Journal
J Nutr Metab
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.35, provisional
iCite
Revised in PubMed
2024-07-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References142

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133520813Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study.J Diabetes Metab Disord2020https://conductscience.org/library/papers/33520813PubMed
235754684The Effect of Curcumin on Lipid Profile and Glycemic Status of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35754684PubMed
3680944Further studies on pharmacology of berberine.Indian J Physiol Pharmacol1978https://conductscience.org/library/papers/680944PubMed
429661513Cinnamon: A systematic review of adverse events.Clin Nutr2019https://conductscience.org/library/papers/29661513PubMed
5281067386-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice.Int J Mol Sci2017https://conductscience.org/library/papers/28106738PubMed
622058071Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism.Mol Nutr Food Res2011https://conductscience.org/library/papers/22058071PubMed
722948795Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats.Phytother Res2013https://conductscience.org/library/papers/22948795PubMed
837748368Effects of curcumin/turmeric supplementation on glycemic indices in adults: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials.Diabetes Metab Syndr2023https://conductscience.org/library/papers/37748368PubMed
933739219The beneficial effects of cinnamon among patients with metabolic diseases: A systematic review and dose-response meta-analysis of randomized-controlled trials.Crit Rev Food Sci Nutr2022https://conductscience.org/library/papers/33739219PubMed
1027861946Saffron: a promising natural medicine in the treatment of metabolic syndrome.J Sci Food Agric2017https://conductscience.org/library/papers/27861946PubMed
118508473Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe.Chem Pharm Bull (Tokyo)1993https://conductscience.org/library/papers/8508473PubMed
1231935866Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials.Nutrients2020https://conductscience.org/library/papers/31935866PubMed
1333041781Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications.Front Pharmacol2020https://conductscience.org/library/papers/33041781PubMed
1432227501The effect of dried Ziziphus vulgaris on glycemic control, lipid profile, Apo-proteins and hs-CRP in patients with type 2 diabetes mellitus: A randomized controlled clinical trial.J Food Biochem2021https://conductscience.org/library/papers/32227501PubMed
1527440832Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?Diabetes Care2016https://conductscience.org/library/papers/27440832PubMed
1616424788Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation.J Cardiovasc Pharmacol2006https://conductscience.org/library/papers/16424788PubMed
1729650089Complementary and Alternative Medicine for Diabetes.Can J Diabetes2018https://conductscience.org/library/papers/29650089PubMed
1810641152Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet.Indian J Exp Biol1999https://conductscience.org/library/papers/10641152PubMed
1931991895Steamed Ginger May Enhance Insulin Secretion through KATP Channel Closure in Pancreatic β-Cells Potentially by Increasing 1-Dehydro-6-Gingerdione Content.Nutrients2020https://conductscience.org/library/papers/31991895PubMed
2024936248Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review.World J Diabetes2014https://conductscience.org/library/papers/24936248PubMed

See all 142 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42275391Production of anti-inflammatory and antidiabetic oligosaccharides from okra mucilage through one-step microbial fermentation.PLoS One2026https://conductscience.org/library/papers/42275391PubMed
41516183Metabolic and Antioxidant Modulation by Artemisia indica Willd. Aqueous Extract in Glucose and Cholesterol Dysregulation.Int J Mol Sci2025https://conductscience.org/library/papers/41516183PubMed
41462455Effect of digital interventions on adherence to the management of type 1 diabetes mellitus patients: a systematic review.BMC Endocr Disord2025https://conductscience.org/library/papers/41462455PubMed
41261111Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis.Nutr Diabetes2025https://conductscience.org/library/papers/41261111PubMed
40872533Lepisanthes alata Attenuates Carrageenan-Induced Inflammation and Pain in Rats: A Phytochemical-Based Approach.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872533PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39021815

GET https://conductscience.org/api/papers/v1/39021815/references?page=2